Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Agilent ( (A) ) has provided an update.
On May 4, 2026, Agilent Technologies Inc. appointed Michael Buckner as chief legal officer, succeeding Bret DiMarco, who resigned from his roles as senior vice president, chief legal officer, and secretary on the same date under a previously disclosed transition agreement. DiMarco will remain with the company as a special advisor through December 1, 2026, to support a smooth handover of responsibilities.
Buckner joins Agilent from Danaher Corp., where he served as vice president, deputy general counsel, and chief M&A counsel, bringing nearly 30 years of experience in complex transactions, governance, and regulatory matters. His background leading global legal teams and driving major deals, including high-profile acquisitions and spin-offs at Danaher and earlier roles at General Electric, is expected to strengthen Agilent’s legal strategy as it advances its growth plans and manages regulatory and transactional risk across its global operations.
The most recent analyst rating on (A) stock is a Buy with a $140.00 price target. To see the full list of analyst forecasts on Agilent stock, see the A Stock Forecast page.
Spark’s Take on A Stock
According to Spark, TipRanks’ AI Analyst, A is a Neutral.
The score is driven most by solid underlying fundamentals and a constructive earnings-call outlook (maintained growth guidance, raised EPS, and margin-expansion/tariff-mitigation plans). These positives are meaningfully offset by a weak technical setup (below key moving averages with negative momentum) and a relatively high P/E with a low dividend yield.
To see Spark’s full report on A stock, click here.
More about Agilent
Agilent Technologies Inc. is a global leader in analytical and clinical laboratory technologies, providing instruments, software, services, and scientific expertise to deliver insights for customers in complex research and diagnostic settings. The company reported fiscal 2025 revenue of $6.95 billion and employs about 18,000 people worldwide, focusing on solutions that help customers address challenging scientific and clinical questions.
Agilent’s market presence spans analytical labs and clinical environments, where its platforms enable testing, measurement, and analysis across pharmaceuticals, life sciences, diagnostics, and related industries. Its broad portfolio positions the company as a key provider of laboratory infrastructure and data-driven solutions, supporting customers’ innovation and regulatory needs in highly technical and regulated markets.
Average Trading Volume: 2,230,618
Technical Sentiment Signal: Sell
Current Market Cap: $32.36B
For detailed information about A stock, go to TipRanks’ Stock Analysis page.